Sepsis is an uncontrolled systemic inflammatory response against an 37 infection and a major public health issue worldwide. This condition affects 38 several organs, and, when caused by Gram-negative bacteria, kidneys are 39 particularly damaged. Due to the importance of renin-angiotensin system 40 (RAS) in regulating renal function, in the present study, we aimed to 41 investigate the effects of endotoxemia over the renal RAS. Wistar rats were 42 injected with E. coli lipopolysaccharide (LPS) (4 mg/kg), mimicking the 43 endotoxemia induced by Gram-negative bacteria. Three days after treatment, 44 body mass, blood pressure and plasma nitric oxide (NO) were reduced, 45
Introduction

Serum, plasma and tissue collection 161 162
Blood and kidneys were collected immediately after euthanasia. Blood 163 was collected into dry or EDTA tubes (BD Vacutainer, New Jersey, USA), 164 centrifuged (3000 rpm, 15 minutes, 4ºC) and supernatant was stored at -80ºC. 165
Kidneys were quickly removed, washed in phosphate buffered saline (PBS) 166 and stored in 10% buffered formalin or frozen at -20°C or -80ºC. 167
168
Creatinine clearance 169 170
Creatinine was measured in urine and serum by Enzymatic Method 171 ( Creatinina K kit, Labtest Diagnóstico, Lagoa Santa, Brazil) , which is based on 172 Jaffe's reaction principle associated to the application of a correction index 173 (8). This methodology minimizes the interference on creatinine determination. 174
The experiment was performed according to manufacturer's instruction and 175 absorbance (510 nm) was read in two time points (30 and improved Griess method (BioAssay, USA). Plasma samples were collected in 210 EDTA tubes and renal tissues were homogenized into PBS (1g tissue: 10mL 211 buffer). Homogenates were centrifuged twice (15000 rpm, 10 minutes, 4ºC). 212
Supernatants were collected and stored at -80ºC. Before the assay, samples 213 were deproteinized. The assay was performed according to manufacturer's 214 instructions. Absorbance (540 nm) The method was performed as previously described (29) . 248
249
Enzymatic activities 250 251
Renin 252
Renin activity was determined by HPLC, according to the method 253 previously described (35). Kidney samples were homogenized in 50 mmol/L 254 Tris buffer pH 7.5 (1 g tissue: 10 mL buffer) containing protease inhibitors (10 255 mmol/L EDTA, 1.0 mmol/L PMSF, 3 μmol/L E64, 1.5 mmol/L, o-256 phenanthroline). Homogenates were centrifuged twice (15000 rpm, 15 257 minutes, 4ºC). Samples (20 μL) were incubated at 37ºC with substrate 258 (tetradecapeptide, 1 nmol/L) in buffering conditions containing the same 259 inhibitors described above at pH 6, reaction was stopped, samples were 260 collected at 0 and 30 minutes and injected in the HPLC system.normalized by protein concentration and expressed in nmol/min/mg of protein.
263
We used as assay control the incubation of homogenate in presence of 264 protease inhibitors containing also aliskiren and pepstatin (10 μmol/L). 265
266
ACE 267
Kidney samples were homogenized in borate buffer pH 7.2 (sodium 268 borohidride 0.4 mol/L, sucrose 0.34 mol/L, NaCl 0.9 mol/L, and protease 269 inhibitor PMSF 1mmol/L, 1 g tissue:10 mL buffer). Homogenates were 270 centrifuged twice (15000 rpm, 15 minutes, 4ºC) and supernatants were stored 271 at -20ºC. ACE activity was determined in spectrofluorimeter (Hitachi F-2000, 272 Japan), using the fluorescent substrate Abz-YRK-EDDnp (10 μmol/L; 273 excitation 320 nm; emission 420 nm). The substrate was added to the buffer 274 (Tris 100 mmol/L, NaCl 50 mmol/L, ZnCl 2 10 μmol/L, pH 7.1) and 275 fluorescence was read (10 minutes, 37ºC). Then, 10 μL of sample was added 276 and read again. Finally, the inhibitor captopril (10 μmol/L) was added for 277 checking ACE's activity. Arbitrary units were registered and calculations were 278 
Neprilysin, cathepsin G and chymase 297 298
Kidney homogenate was prepared as described above in the 299 respective buffers used to quantify neprilysin, cathepsin and chymase 300 activities. The fluorogenic substrates were produced by AminoTech Pesquisa 301 e Desenvolvimento (Brasil) . 302
The neprilysin activity was measured after pre-incubation of 10 µL of 303 kidney homogenate from control and endotoxemia groups with captopril (10 304 μmol/L), aliskiren (10 μmol/L) at 37°C for 30 minutes in 50 mmol/L Tris/HCl 305 buffer, pH 7.4, in plates from the Infinite 200 apparatus (Tecan, Switzerland), 306
EDDnp= 2,4-dinitrophenyl ethylenediamine) substrate addition. Fluorescence 308 was measured continuously at λ ex =320 nm and λ em = 420nm. The same 309 procedure was carried out using 50 nmol/L of the specific inhibitor Thiorphan. 310
The proteolytic activity was expressed as μM/min/mg of protein. 
Statistical analysis 355 356
Values were represented as mean (X) ± standard error of the mean 357 (SEM). Data from endotoxemic group were compared to control group by two-358 tails non-dependent t-Test. The significance level (p-value) of 5% was 359 considered statistically significant. 360
Results 363 364 LPS dose was determined by dose-response tests in small groups of 365 animals (n=3). LPS was injected in Wistar rats intraperitoneally in the 366 following doses (mg/kg): 1, 2, 4 and 8. Twenty-four hours after treatment, the 367 group LPS 8 mg/kg reached 100% of mortality, but animals treated with lower 368 LPS doses survived through the three-day treatment, as expected in our 369
protocol. Blood pressure and body weight were measured twice before LPS 370 injection and once 3 days after treatment. All tested doses reduced body 371 weight, but only the doses 2 and 4 mg/kg affected blood pressure. Thus, as 372 long as rodents are resistant to LPS effects, we chose LPS 4 mg/kg for the 373 following steps of our work (data not shown). kDa-band is in accordance with the molecular mass previously described byour team (2). Two bands of ACE were detected with different molecular 397 masses (120 kDa and 65 kDa), indicating the presence of two isoforms, as 398 previously found by our team (29). In the present work, only the 120 kDa 399 isoform was down regulated (Figures 5.C) . 400 RAS enzymes activities in renal tissue were also affected by LPS 401 injection, while renin and ACE presented reduced activities in endotoxemic 402 animals, ACE2 activity was increased in LPS-treated animals ( Figure 6) . The 403 renin activity tested was inhibited by aliskiren 86% and 97% in control and 404 endotoxemia groups, respectively. Additionally, the activity was inhibited by 405 pepstatin 71.5% and 76% in control and endotoxemia groups, respectively. 406
Based on the increased levels of Ang II and reduced renin activity, we 407 tested the alternative RAS enzyme pathways for peptide generation 408 quantifying cathepsin G and chymase activities. The cathepsin G activity was 409 significantly higher in the endotoxemia group when compared to control (1.80 410 vs 2.37 μM/min/mg of protein) (n=3, p<0.05), and also for chymase activity 411 Sepsis is a highly complex disease, which might trigger several types 428 of host responses, depending on a number of factors. Although thesecharacteristics restrain the possibility of fully mimicking that condition, animal 430 models are still essential tools for studying biological processes. In sepsis 431 studies, LPS injection was chosen as one of the main methods for mimicking 432 endotoxemic shock and its renal outcomes (26, 27, 40) . 433
Since high doses of LPS provoke cardiovascular collapse and low 434 doses induce hyperdynamic response (26, 27), we tested several doses of 435 LPS (data not shown). We standardized 4 mg/kg for the subsequent 436 treatments, since that dose reduced blood pressure and body mass three 437 days after treatment, indicating cardiovascular and metabolic alterations. 438
These complications are typical from endotoxemia, since they are triggered by 439 disturbances of hemodynamic, substrate turnover, hormonal pattern and 440 protein catabolism (6). 441
Our data is in accordance to Tsai et al, that observed reduction of 442 blood pressure after intravenous LPS injection, reaching low levels in the first 443 hours of treatment (33). Despite this hypotension, creatinine clearance 444 remained unchanged, indicating that GFR was not affected. Previous studies 445 also showed that creatinine clearance was preserved 24h after LPS injection 446 in Wistar rats (24). It is important to highlight that the triggering of AKI does 447 not require renal hemodynamics alterations (1). 448
Concerning systemic inflammation, endotoxemia did not affect plasma 449
pro-inflammatory cytokines levels, what can be explained by the specie-450 specific sensitivity to LPS. Rodents are more resistant to LPS effects than 451 primates, presenting brief augmentation of cytokines levels. Therefore, 452 endotoxemia induction in rodents requires higher LPS doses, what greatly 453 activates innate immune system but causes early and transient release of pro-454 inflammatory cytokines (27, 40). Thus, our prolonged treatment might have 455 allowed the cytokines levels returning back to normal. Besides, the 456 unchanged cytokines levels could also be related to the maintenance of GFR 457 after LPS injection, since they contribute to systemic hypotension and renal 458
injury (24). 459
Plasma NO greatly reduced in endotoxemic group, indicating that NO-460 independent mechanisms maintained the hypotension, like prostacyclin 461 pathway. In this regards, the kallikrein-kinin system becomes important, 462 because the activation of the type 1 bradykinin receptor (B 1 R) inducesprostacyclin release. Furthermore, LPS and vascular dysfunction, an early 464 event from endotoxemia, activate this system, and it was demonstrated that 465 the B 1 R blockage partially reverts the hypotension in sepsis animal models 466 (22). Besides, it was already reported that there are iNOS-dependent and 467
iNOS-independent pathways to trigger LPS-induced hypotension and death 468 (19). 469
Other authors presented results similar to ours (19, 39) . Their data 470 suggest that NO-independent pathways might be important controllers of 471 vascular tonus during endotoxemia. In these previous studies, typical 472 cardiovascular effects of LPS were observed even in the absence of changes 473 in NO levels and/or iNOS modulation. These works support our findings, in 474 which LPS-treated animals presented decreased blood pressure despite the 475 reduced levels of plasma NO and renal iNOS expression. it is known that there are two phases of ROS production: one is early and 500 transient and the other is late and sustained. The first phase is due to 501 NAD(P)H acute activation by Ang II and the second phase depends on this 502 early event, being a consequence from the augmented expression of different 503 NAD(P)H subunits (12, 23) . Unaltered ROS levels may be related to our 504 three-day treatment, which could not have been enough to reach the late 505 phase of ROS production in kidneys. This might be a compensatory 506 mechanism as an attempt for reducing the deleterious effects of endotoxemia. 507
After quantifying angiotensin peptides, we evaluated other components 508 of the system. Endotoxemia induced reduction of renin activity without effects 509 over protein expression. Previous works showed results similar to ours, when 510 human mesangial cells are exposed to LPS; renin activity reduces without 511 alteration of its protein expression or AGT's (1). The mechanism whereby LPS 512 modulates renin activity remains unknown; however LPS activates several 513 biochemical pathways and mesangial cells express the required molecular 514 machinery for LPS binding. Thus, the activation of signaling pathways or the 515 production of some factors by LPS stimulus might influence renin activity. 516
Another possibility is that LPS could affect renin directly, by inhibiting the 517 enzyme itself or by modulating its co-factors. 518
Regarding ACE, reduction of protein expression and enzyme activity 519 suggest a physiological attempt of regulating renal function, since ACE 520 controls renal vascular tonus by producing the vasoconstrictor Ang II and 521 degrading the vasodilator bradykinin (11). The modulation of ACE could have 522 resulted from the action of factors and peptides released during endoxemia, 523 since changes in microenvironment influence several biological processes. 524
The shedding mechanism is also capable of regulating ACE biological activity 525 and LPS induces the enzyme shedding in human umbilical vein endothelial 526 cells, according to English et al (11) . Previous works from our group identified 527 ACE shedding in several cells types, like mesangial cells, proximal tubules 528 cells and collecting duct cells (7, 28) . Thus, in our model, endotoxemia could 529 have induced ACE shedding, modulating its expression and activity.
Another possible regulator of Ang II level is ACE2 and, since LPS 531 increased its activity, higher amount of Ang II could have been degraded. It is 532 expected that augmented degradation of Ang II by ACE2 cleavage would 533 cause growth of Ang (1-7) production, however, our data shows no statistic 534 difference on Ang (1-7) levels between control and endotoxemia groups. This 535 situation suggests that ACE2 is mainly acting on other peptides, for instance, 536
Ang I. Besides the maintenance of ACE2 protein expression levels, factors 537 released locally may influence enzyme activities directly. No changes in 538 protein expression between groups with increase in activity of one of them 539 were detected. It is important to note that this can occur considering that 540 proteins are flexible and rapidly fluctuating molecules whose structural 541 mobility have functional significance and can stimulate the activity. Also we 542 can emphasize that an enzyme's substrate-binding affinity may vary with the 543 binding of small molecule effectors thereby changing the enzyme's catalytic 544 activity activating or inhibiting it physiologically. Increased ACE2 activity may 545 represent an attempt of controlling tissue damage induced by augmented 546
Ang II, playing a protective role in kidneys (9, 14) . 547
We found that cathepsin G and chymase activities increased 548 significantly in the endotoxemia group suggesting a parallel pathway for non-549 renin-dependent Ang II formation. 550
Taken together, our data suggest that alternative pathways for Ang II 551 production are activated in LPS-treated animals, due to increased levels of 552 Ang II not accompanied by changes of Ang I levels or ACE activity. For 553 instance, cathepsin G generate Ang II directly from Ang I or AGT. Chymase is 554 another example, since it converts Ang I to Ang II and has been described in 555 several tissues. Still, during endotoxemia, cathepsin G stands out, because it 556 is highly expressed by monocytes and neutrophils, becoming important for 557 inflammatory response regulation. Thus, that enzyme may also contribute to 558 local Ang II production, modulating blood flow and cellular aggregation. 559
Furthermore, cathepsin G generates Ang II in the same magnitude as ACE 560 does and its emergence in kidneys is strongly related to inflammatory 561 processes (30) . 562
In the present study the effects of systemic LPS administration over 563 renal RAS were studied. It is important to highlight that a long-term LPStreatment was used, in comparison to short-term, used by most works. We 565 found some unique results, like diminished NO levels in plasma despite 566 reduced blood pressure. Since our animal model reproduces mainly the renal 567 effects of sepsis and RAS regulates renal function, we tried to elucidate the 568 effects of endotoxemia specifically over renal RAS. 569
In conclusion, our treatment was capable of influencing renal RAS and 570 activating some compensatory mechanisms, as an attempt of minimizing 571 LPS-induced damage. Reduced renin and ACE renal activities indicate that 572 alternative pathways, through the cathepsin G and chymase activities are 573 important for Ang II production and the increased ACE2 renal activity 574 suggests that its degradation is compromised in our endotoxemia model. Clearance. Endotoxemic and control groups' physiological parameters were 591 analyzed and compared as described in methods. Tail cuff blood pressure (A) 592 and body mass (B) remained unchanged between groups three days before 593 and on the day of LPS treatment (day -3 and 0, respectively); both parameters 594 were reduced and three days after LPS injection (day 3) LPS. Creatinine 595 clearance (C) was calculated according to the dosages performed in urine 596 collected from the second to the third day after LPS injection and in serum 597 collected during euthanasia, no statistical difference was found between 598 groups. (n=6) X±SEM, Endotoxemia vs. Control *p≤0.05. 599 
